Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The slow sodium channel, also known as the persistent sodium current (INaP), is a non-inactivating or slowly inactivating component of the voltage-gated sodium current. It persists at subthreshold voltages and does not fully inactivate during sustained depolarizations. INaP regulates neuronal excitability, contributes to action potential bursting and pacemaking, and is implicated in epilepsy and cardiac arrhythmia. The current is primarily mediated by voltage-gated sodium channels (NaVs), with the Nav1.6 isoform being particularly important. Multiple mechanisms contribute to its persistence, including modal gating, window current, and auxiliary subunit modulation. Its magnitude can be dynamically regulated by various factors, including alternative mRNA splicing, extracellular calcium concentration, protein kinases, G-protein coupled receptors, and oxygen concentration.
Inhibition of persistent sodium current
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Slow Sodium Channel (None).